Abstract: Background: Optimal treatment duration for immune checkpoint inhibitors (ICI) remains a clinical debate. The objective of this study was to contrast mortality rates …
Abstract: Objective: The objective of this study was to examine the relationship between clozapine use and hematologic malignancies, using national administrative data from the …
Abstract: Background: Immune checkpoint inhibitors (ICIs) are associated with potentially severe immune-related adverse events (irAEs). Emerging clinical practice reports have …
Abstract: The Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Services created a national stewardship with focus on anti-cancer therapeutics within a …